Scientech Research »

Dyne Therapeutics shares owned by Scientech Research

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Scientech Research from 13F filings

Historical chart of Scientech Research investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Scientech Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Scientech Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $192k 11k 18.13

More positions owned by Scientech Research

Applied Digital Corp Com New (APLD)
Wave Life Sciences SHS (WVE)
Echostar Corp Cl A (SATS)
Themes Etf Tr Leverage Shs 2x (CRCG)
Scholar Rock Hldg Corp (SRRK)
Miragen Therapeutics (VRDN)
Figma Class A Com Stk (FIG)
Century Aluminum Company (CENX)
Oklo Com Cl A (OKLO)
Coinbase Global Com Cl A (COIN)
Five Below (FIVE)
Cytomx Therapeutics (CTMX)
Graniteshares Etf Tr 2x Long Coin Dai (CONL)
Snowflake Com Shs (SNOW)
Planet Labs Pbc Com Cl A (PL)

View all positions for Scientech Research

Top funds holding Dyne Therapeutics

T. Rowe Price Investment Management
Henderson Group
BlackRock
Vanguard Group
Atlas Venture Life Science Advisors
Orbis Allan Gray
State Street Corporation
FMR
Vanguard Capital Management
Fcpm Iii Services B.v.
Adage Capital Partners GP
Perceptive Advisors
TCG Crossover Management
Vanguard Portfolio Management
Vestal Point Capital

View all funds holding Dyne Therapeutics